Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Vincerx Pharma, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −2 vs. Q3 2023
- Shares held
- 9.85M
- −857.6K (−8.0%) vs. Q3 2023
- Total value
- $11.6M
- +$796.2K (+7.4%) vs. Q3 2023
- New holders
- 1
- 3 more added
- Sold out
- 3
- 8 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VINC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $2 |
| Q1 2025 | 14 | $116.8K |
| Q4 2024 | 21 | $1.26M |
| Q3 2024 | 26 | $7.89M |
| Q2 2024 | 28 | $8.66M |
| Q1 2024 | 38 | $42.7M |
| Q4 2023 | 33 | $11.6M |
| Q3 2023 | 35 | $10.8M |
| Q2 2023 | 34 | $15.7M |
| Q1 2023 | 35 | $13.3M |
| Q4 2022 | 34 | $13.0M |
| Q3 2022 | 43 | $20.0M |
| Q2 2022 | 49 | $18.4M |
| Q1 2022 | 65 | $65.1M |
| Q4 2021 | 55 | $156.8M |
| Q3 2021 | 55 | $248.9M |
| Q2 2021 | 56 | $157.3M |
| Q1 2021 | 36 | $171.0M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Vincerx Pharma, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 1,709,656 | $2.02M | 0.00% | −353,270−17.1% | Reduced |
| Sage Rhino Capital LLC | 1,703,413 | $2.01M | 0.52% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 1,098,753 | $1.30M | 0.17% | 00.0% | Unchanged |
| Bank of America Corp | 1,082,863 | $1.28M | 0.00% | −370,044−25.5% | Reduced |
| Rock Springs Capital Management LP | 891,719 | $1.05M | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 513,420 | $605.8K | 0.00% | 00.0% | Unchanged |
| Kingdon Capital Management, L.L.C. | 385,000 | $454.3K | 0.09% | 00.0% | Unchanged |
| Rubric Capital Management LP | 354,377 | $418.2K | 0.02% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 344,827 | $406.9K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 324,119 | $382.0K | 0.00% | −65,393−16.8% | Reduced |
| Tejara Capital Ltd | 233,348 | $275.4K | 0.12% | 00.0% | Unchanged |
| Citadel Advisors LLC | 197,359 | $232.9K | 0.00% | +28,530+16.9% | Added |
| Renaissance Technologies LLC | 176,020 | $208.0K | 0.00% | +43,120+32.4% | Added |
| Geode Capital Management, LLC | 154,031 | $181.8K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 115,044 | $135.8K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 114,000 | $135.1K | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 102,049 | $120.4K | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 64,259 | $75.8K | 0.00% | 00.0% | Unchanged |
| Marex Group plc | 49,404 | $58.3K | 0.00% | +49,404 | New |
| State Street Corp | 43,143 | $50.9K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 40,000 | $48.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 41,830 | $48.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 34,468 | $40.7K | 0.00% | −2,586−7.0% | Reduced |
| Northern Trust Corp | 25,614 | $30.2K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 17,755 | $21.0K | 0.00% | −7,067−28.5% | Reduced |
| Wade G W & Inc | 10,900 | $13.0K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 10,000 | $11.8K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,349 | $6.31K | 0.00% | −1,829−25.5% | Reduced |
| UBS Group AG | 2,949 | $3.48K | 0.00% | −2,787−48.6% | Reduced |
| Wells Fargo & Company | 133 | $157 | 0.00% | +7+5.6% | Added |
| Barclays PLC | 23 | $27 | 0.00% | −2,533−99.1% | Reduced |
| FMR LLC | 6 | $7 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 4 | $5 | 0.00% | 00.0% | Unchanged |
| Clearline Capital LP | 0 | $0 | 0.00% | −98,916−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −57,353−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −16,845−100.0% | Sold out |